This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Inventor Spotlight: Pavol Rajniak
Introduction
Pavol Rajniak, a notable inventor based in Lansdale, Pennsylvania, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Rajniak is recognized for his innovative approach to drug formulation and development.
Latest Patents
Rajniak's most recent patents focus on "Formulations of suberoylanilide hydroxamic acid and methods for producing same." This invention provides a pharmaceutical composition or crystalline composition that features a specific dissolution profile. It includes suberoylanilide hydroxamic acid or a pharmaceutically acceptable salt or hydrate thereof as an active ingredient. The invention details a process for producing the crystalline composition or pharmaceutical composition, along with compositions that possess a specific particle size distribution. This innovative work emphasizes Rajniak's dedication to improving pharmaceutical formulations.
Career Highlights
Currently, Pavol Rajniak is employed at Merck Sharp & Dohme Corporation, where he continues to innovate within the pharmaceutical industry. His expertise in pharmaceutical composition and formulation not only demonstrates his skills as an inventor but also underscores his commitment to contributing positively to health sciences.
Collaborations
Throughout his career, Rajniak has had the opportunity to collaborate with talented individuals such as Jeannie Chow Wong and Aaron S. Cote. These partnerships emphasize the collaborative nature of innovation in the field, showcasing how teamwork can lead to groundbreaking advancements.
Conclusion
Pavol Rajniak stands out as a significant figure in the realm of pharmaceutical innovation. With his focus on suberoylanilide hydroxamic acid formulations and his esteemed career at Merck Sharp & Dohme Corporation, he continues to pave the way for future advancements in medication development. His contributions reflect the persistent spirit of innovation that drives progress in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile